LLY logo

Eli Lilly And Company (LLY) Cash From Operations

Annual CFO

$4.24 B
-$3.35 B-44.10%

31 December 2023

LLY Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$3.71 B
+$2.25 B+153.16%

30 September 2024

LLY Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$6.03 B
+$1.52 B+33.76%

30 September 2024

LLY TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LLY Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-44.1%+69.5%-2.9%
3 y3 years-34.8%+127.5%-12.8%
5 y5 years-23.3%+145.8%+39.6%

LLY Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-44.1%at lowat high+1290.1%-26.4%+64.1%
5 y5 years-44.1%at lowat high+1290.1%-26.4%+64.1%
alltimeall time-44.1%+310.6%at high+1077.8%-26.4%+1901.4%

Eli Lilly And Company Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
$3.71 B(+153.2%)
$6.03 B(+33.8%)
June 2024
-
$1.47 B(+25.7%)
$4.51 B(+22.7%)
Mar 2024
-
$1.17 B(-473.8%)
$3.68 B(-13.3%)
Dec 2023
$4.24 B(-44.1%)
-$311.90 M(-114.2%)
$4.24 B(-31.8%)
Sept 2023
-
$2.19 B(+246.5%)
$6.21 B(-0.4%)
June 2023
-
$631.90 M(-63.5%)
$6.24 B(-8.1%)
Mar 2023
-
$1.73 B(+4.1%)
$6.79 B(-10.4%)
Dec 2022
$7.59 B(+3.0%)
$1.66 B(-25.0%)
$7.59 B(-7.3%)
Sept 2022
-
$2.22 B(+87.3%)
$8.18 B(+7.7%)
June 2022
-
$1.18 B(-53.1%)
$7.60 B(-7.2%)
Mar 2022
-
$2.52 B(+11.6%)
$8.19 B(+11.2%)
Dec 2021
$7.37 B(+13.3%)
$2.26 B(+38.6%)
$7.37 B(+6.5%)
Sept 2021
-
$1.63 B(-8.1%)
$6.92 B(-2.5%)
June 2021
-
$1.78 B(+4.6%)
$7.09 B(-9.2%)
Mar 2021
-
$1.70 B(-6.5%)
$7.81 B(+20.2%)
Dec 2020
$6.50 B(+34.4%)
$1.82 B(+0.5%)
$6.50 B(-2.2%)
Sept 2020
-
$1.81 B(-27.6%)
$6.65 B(+4.7%)
June 2020
-
$2.50 B(+552.6%)
$6.35 B(+29.4%)
Mar 2020
-
$382.40 M(-80.5%)
$4.91 B(+1.5%)
Dec 2019
$4.84 B(-12.5%)
$1.96 B(+30.0%)
$4.84 B(+11.9%)
Sept 2019
-
$1.51 B(+43.6%)
$4.32 B(-12.4%)
June 2019
-
$1.05 B(+237.8%)
$4.93 B(-8.6%)
Mar 2019
-
$311.30 M(-78.5%)
$5.40 B(-2.3%)
Dec 2018
$5.52 B(-1.6%)
$1.45 B(-31.7%)
$5.52 B(-5.1%)
Sept 2018
-
$2.12 B(+39.8%)
$5.82 B(+4.3%)
June 2018
-
$1.52 B(+247.7%)
$5.58 B(-2.3%)
Mar 2018
-
$436.50 M(-75.0%)
$5.71 B(+1.7%)
Dec 2017
$5.62 B(+15.8%)
$1.74 B(-7.3%)
$5.62 B(-4.5%)
Sept 2017
-
$1.88 B(+13.9%)
$5.88 B(+3.9%)
June 2017
-
$1.65 B(+385.8%)
$5.66 B(+4.6%)
Mar 2017
-
$339.90 M(-83.1%)
$5.41 B(+11.5%)
Dec 2016
$4.85 B(+63.6%)
$2.01 B(+20.7%)
$4.85 B(+26.3%)
Sept 2016
-
$1.66 B(+18.5%)
$3.84 B(+17.0%)
June 2016
-
$1.40 B(-739.8%)
$3.28 B(+16.0%)
Mar 2016
-
-$219.10 M(-122.0%)
$2.83 B(-4.5%)
Dec 2015
$2.96 B(-33.5%)
$996.10 M(-9.8%)
$2.96 B(-13.0%)
Sept 2015
-
$1.10 B(+16.5%)
$3.41 B(-14.7%)
June 2015
-
$948.60 M(-1218.6%)
$4.00 B(-2.6%)
Mar 2015
-
-$84.80 M(-105.9%)
$4.10 B(-8.0%)
Dec 2014
$4.46 B(-22.3%)
$1.44 B(-14.8%)
$4.46 B(-6.0%)
Sept 2014
-
$1.69 B(+60.5%)
$4.74 B(-6.0%)
June 2014
-
$1.05 B(+287.0%)
$5.04 B(-10.4%)
Mar 2014
-
$272.30 M(-84.2%)
$5.63 B(-1.9%)
Dec 2013
$5.74 B(+8.1%)
$1.73 B(-13.3%)
$5.74 B(+2.2%)
Sept 2013
-
$1.99 B(+21.6%)
$5.61 B(+8.7%)
June 2013
-
$1.64 B(+331.5%)
$5.16 B(+6.9%)
Mar 2013
-
$379.40 M(-76.3%)
$4.83 B(-8.9%)
Dec 2012
$5.30 B(-26.7%)
$1.60 B(+3.7%)
$5.30 B(-6.1%)
Sept 2012
-
$1.54 B(+18.2%)
$5.65 B(-8.6%)
June 2012
-
$1.31 B(+53.2%)
$6.18 B(-10.6%)
Mar 2012
-
$852.50 M(-56.2%)
$6.91 B(-4.5%)
Dec 2011
$7.23 B(+5.5%)
$1.94 B(-6.2%)
$7.23 B(-3.8%)
Sept 2011
-
$2.07 B(+1.6%)
$7.52 B(+4.4%)
June 2011
-
$2.04 B(+73.5%)
$7.20 B(+1.8%)
Mar 2011
-
$1.18 B(-47.2%)
$7.07 B(+3.2%)
Dec 2010
$6.86 B(+58.2%)
$2.23 B(+26.7%)
$6.86 B(+3.2%)
Sept 2010
-
$1.76 B(-8.0%)
$6.65 B(+7.3%)
June 2010
-
$1.91 B(+99.5%)
$6.19 B(+19.0%)
Mar 2010
-
$958.00 M(-52.5%)
$5.21 B(+20.1%)
Dec 2009
$4.34 B(-40.6%)
$2.02 B(+54.6%)
$4.34 B(-7.7%)
Sept 2009
-
$1.31 B(+41.4%)
$4.70 B(-15.0%)
June 2009
-
$923.30 M(+950.4%)
$5.52 B(-2.8%)
Mar 2009
-
$87.90 M(-96.3%)
$5.68 B(-22.1%)
Dec 2008
$7.30 B(+41.5%)
$2.38 B(+11.7%)
$7.30 B(+2.1%)
Sept 2008
-
$2.13 B(+97.2%)
$7.14 B(+10.6%)
June 2008
-
$1.08 B(-36.5%)
$6.46 B(+8.3%)
Mar 2008
-
$1.70 B(-23.6%)
$5.97 B(+15.7%)
Dec 2007
$5.15 B
$2.23 B(+54.4%)
$5.15 B(+7.8%)
Sept 2007
-
$1.44 B(+145.5%)
$4.78 B(+5.9%)
June 2007
-
$588.50 M(-34.0%)
$4.51 B(-2.2%)
DateAnnualQuarterlyTTM
Mar 2007
-
$891.80 M(-52.0%)
$4.61 B(+16.0%)
Dec 2006
$3.98 B(+107.8%)
$1.86 B(+58.0%)
$3.98 B(+35.6%)
Sept 2006
-
$1.18 B(+71.0%)
$2.93 B(+113.0%)
June 2006
-
$687.70 M(+170.2%)
$1.38 B(+1.0%)
Mar 2006
-
$254.50 M(-68.7%)
$1.36 B(-28.8%)
Dec 2005
$1.91 B(-33.3%)
$814.30 M(-314.5%)
$1.91 B(+16.1%)
Sept 2005
-
-$379.60 M(-156.3%)
$1.65 B(-41.7%)
June 2005
-
$674.10 M(-16.2%)
$2.83 B(-8.7%)
Mar 2005
-
$804.80 M(+46.8%)
$3.10 B(+7.9%)
Dec 2004
$2.87 B(-21.3%)
$548.40 M(-31.4%)
$2.87 B(-17.7%)
Sept 2004
-
$799.90 M(-15.3%)
$3.49 B(-7.0%)
June 2004
-
$944.20 M(+63.6%)
$3.75 B(+3.2%)
Mar 2004
-
$577.00 M(-50.5%)
$3.63 B(-0.3%)
Dec 2003
$3.65 B(+76.1%)
$1.17 B(+9.7%)
$3.65 B(+14.9%)
Sept 2003
-
$1.06 B(+28.4%)
$3.18 B(+18.4%)
June 2003
-
$828.00 M(+40.6%)
$2.68 B(+10.7%)
Mar 2003
-
$589.00 M(-15.3%)
$2.42 B(+16.9%)
Dec 2002
$2.07 B(-43.4%)
$695.00 M(+22.1%)
$2.07 B(-15.7%)
Sept 2002
-
$569.20 M(+0.2%)
$2.46 B(-15.9%)
June 2002
-
$568.30 M(+138.6%)
$2.92 B(-13.4%)
Mar 2002
-
$238.20 M(-78.0%)
$3.37 B(-7.9%)
Dec 2001
$3.66 B(-1.9%)
$1.08 B(+4.6%)
$3.66 B(+0.0%)
Sept 2001
-
$1.03 B(+1.3%)
$3.66 B(-5.3%)
June 2001
-
$1.02 B(+93.3%)
$3.87 B(+6.0%)
Mar 2001
-
$527.60 M(-51.1%)
$3.65 B(-2.2%)
Dec 2000
$3.73 B(+42.4%)
$1.08 B(-12.9%)
$3.73 B(+3.6%)
Sept 2000
-
$1.24 B(+54.8%)
$3.60 B(+5.2%)
June 2000
-
$801.10 M(+31.3%)
$3.42 B(+2.5%)
Mar 2000
-
$610.20 M(-35.8%)
$3.34 B(+27.5%)
Dec 1999
$2.62 B(-0.4%)
$951.20 M(-10.4%)
$2.62 B(-3.8%)
Sept 1999
-
$1.06 B(+48.2%)
$2.72 B(+11.4%)
June 1999
-
$716.30 M(-756.0%)
$2.45 B(-0.7%)
Mar 1999
-
-$109.20 M(-110.3%)
$2.46 B(-6.3%)
Dec 1998
$2.63 B(+9.6%)
$1.06 B(+34.8%)
$2.63 B(+3.8%)
Sept 1998
-
$782.90 M(+6.6%)
$2.53 B(+12.9%)
June 1998
-
$734.10 M(+1181.2%)
$2.24 B(+4.2%)
Mar 1998
-
$57.30 M(-94.0%)
$2.15 B(-10.3%)
Dec 1997
$2.40 B(+20.5%)
$959.00 M(+94.0%)
$2.40 B(+11.9%)
Sept 1997
-
$494.30 M(-23.2%)
$2.14 B(+0.7%)
June 1997
-
$643.40 M(+111.9%)
$2.13 B(+2.7%)
Mar 1997
-
$303.70 M(-56.8%)
$2.07 B(+4.2%)
Dec 1996
$1.99 B(+9.1%)
$703.40 M(+46.4%)
$1.99 B(-3.1%)
Sept 1996
-
$480.40 M(-18.1%)
$2.05 B(+9.0%)
June 1996
-
$586.60 M(+165.4%)
$1.89 B(+7.0%)
Mar 1996
-
$221.00 M(-71.2%)
$1.76 B(-3.4%)
Dec 1995
$1.82 B(+19.1%)
$766.60 M(+146.3%)
$1.82 B(+14.0%)
Sept 1995
-
$311.20 M(-32.8%)
$1.60 B(-10.7%)
June 1995
-
$463.00 M(+63.1%)
$1.79 B(+8.7%)
Mar 1995
-
$283.80 M(-47.7%)
$1.65 B(+7.6%)
Dec 1994
$1.53 B(+1.0%)
$542.70 M(+8.0%)
$1.53 B(+0.9%)
Sept 1994
-
$502.30 M(+57.4%)
$1.52 B(+0.7%)
June 1994
-
$319.20 M(+89.9%)
$1.51 B(-0.2%)
Mar 1994
-
$168.10 M(-68.2%)
$1.51 B(-0.5%)
Dec 1993
$1.52 B(+2.3%)
$528.30 M(+7.5%)
$1.52 B(-10.2%)
Sept 1993
-
$491.30 M(+52.6%)
$1.69 B(+17.4%)
June 1993
-
$322.00 M(+83.7%)
$1.44 B(+3.5%)
Mar 1993
-
$175.30 M(-75.0%)
$1.39 B(-6.3%)
Dec 1992
$1.48 B(+18.2%)
$699.90 M(+190.4%)
$1.48 B(+21.5%)
Sept 1992
-
$241.00 M(-11.8%)
$1.22 B(-15.9%)
June 1992
-
$273.20 M(+1.4%)
$1.45 B(+8.6%)
Mar 1992
-
$269.40 M(-38.4%)
$1.34 B(+6.4%)
Dec 1991
$1.25 B(-14.9%)
$437.00 M(-7.3%)
$1.25 B(-0.3%)
Sept 1991
-
$471.40 M(+198.9%)
$1.26 B(-1.2%)
June 1991
-
$157.70 M(-16.3%)
$1.27 B(-6.4%)
Mar 1991
-
$188.50 M(-57.3%)
$1.36 B(-7.7%)
Dec 1990
$1.47 B(+42.8%)
$441.10 M(-9.4%)
$1.47 B(+42.7%)
Sept 1990
-
$486.60 M(+98.4%)
$1.03 B(+89.0%)
June 1990
-
$245.30 M(-18.6%)
$546.70 M(+81.4%)
Mar 1990
-
$301.40 M
$301.40 M
Dec 1989
$1.03 B
-
-

FAQ

  • What is Eli Lilly and Company annual cash flow from operations?
  • What is the all time high annual CFO for Eli Lilly and Company?
  • What is Eli Lilly and Company annual CFO year-on-year change?
  • What is Eli Lilly and Company quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly CFO year-on-year change?
  • What is Eli Lilly and Company TTM cash flow from operations?
  • What is the all time high TTM CFO for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM CFO year-on-year change?

What is Eli Lilly and Company annual cash flow from operations?

The current annual CFO of LLY is $4.24 B

What is the all time high annual CFO for Eli Lilly and Company?

Eli Lilly and Company all-time high annual cash flow from operations is $7.59 B

What is Eli Lilly and Company annual CFO year-on-year change?

Over the past year, LLY annual cash flow from operations has changed by -$3.35 B (-44.10%)

What is Eli Lilly and Company quarterly cash flow from operations?

The current quarterly CFO of LLY is $3.71 B

What is the all time high quarterly CFO for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly cash flow from operations is $3.71 B

What is Eli Lilly and Company quarterly CFO year-on-year change?

Over the past year, LLY quarterly cash flow from operations has changed by +$1.52 B (+69.53%)

What is Eli Lilly and Company TTM cash flow from operations?

The current TTM CFO of LLY is $6.03 B

What is the all time high TTM CFO for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM cash flow from operations is $8.19 B

What is Eli Lilly and Company TTM CFO year-on-year change?

Over the past year, LLY TTM cash flow from operations has changed by -$182.50 M (-2.94%)